The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort
Babayigit et al.,
The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide..,
Frontiers in Medicine, doi:10.3389/fmed.2022.894126
Retrospective 1,472 hospitalized patients in Turkey, showing a higher risk of ICU admission and ventilation with HCQ, without statistical significance.
risk of mechanical ventilation, 112.4% higher, RR 2.12, p = 0.21, treatment 63 of 1,378 (4.6%), control 6 of 94 (6.4%), adjusted per study, odds ratio converted to relative risk, multivariable.
|
risk of ICU admission, 52.8% higher, RR 1.53, p = 0.33, treatment 107 of 1,363 (7.9%), control 9 of 93 (9.7%), adjusted per study, odds ratio converted to relative risk, multivariable.
|
hospitalization time, 16.7% higher, relative time 1.17, p = 0.05, treatment 852, control 63.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Babayigit et al., 31 Aug 2022, retrospective, Turkey, peer-reviewed, mean age 51.9, 68 authors, study period 11 March, 2020 - 18 July, 2020.
Contact:
habayram@ku.edu.tr.
Abstract: TYPE Original Research
PUBLISHED
31 August 2022
DOI 10.3389/fmed.2022.894126
OPEN ACCESS
EDITED BY
Esmaeil Mortaz,
National Research Institute
of Tuberculosis and Lung Diseases
(NRITLD), Iran
The association of antiviral
drugs with COVID-19 morbidity:
The retrospective analysis of a
nationwide COVID-19 cohort
REVIEWED BY
Burcin Halacli,
Hacettepe University, Turkey
Ahmed Mostafa,
National Research Centre, Egypt
Juliana Ferreira,
University of São Paulo, Brazil
*CORRESPONDENCE
Hasan Bayram
habayram@ku.edu.tr
SPECIALTY SECTION
This article was submitted to
Pulmonary Medicine,
a section of the journal
Frontiers in Medicine
RECEIVED 11 March 2022
ACCEPTED 11 August 2022
PUBLISHED 31 August 2022
CITATION
Babayigit C, Kokturk N, Kul S,
Cetinkaya PD, Atis Nayci S,
Argun Baris S, Karcioglu O, Aysert P,
Irmak I, Akbas Yuksel A, Sekibag Y,
Baydar Toprak O, Azak E,
Mulamahmutoglu S, Cuhadaroglu C,
Demirel A, Kerget B,
Baran Ketencioglu B, Ozger HS,
Ozkan G, Ture Z, Ergan B,
Avkan Oguz V, Kilinc O, Ercelik M,
Ulukavak Ciftci T, Alici O,
Nurlu Temel E, Ataoglu O, Aydin A,
Cetiner Bahcetepe D, Gullu YT, Fakili F,
Deveci F, Kose N, Tor MM,
Gunluoglu G, Altin S, Turgut T, Tuna T,
Ozturk O, Dikensoy O, Yildiz Gulhan P,
Basyigit I, Boyaci H, Oguzulgen IK,
Borekci S, Gemicioglu B, Bayraktar F,
Elbek O, Hanta I, Kuzu Okur H,
Sagcan G, Uzun O, Akgun M,
Altinisik G, Dursun B, Cakir Edis E,
Gulhan E, Oner Eyuboglu F, Gultekin O,
Havlucu Y, Ozkan M, Sakar Coskun A,
Sayiner A, Kalyoncu AF, Itil O and
Bayram H (2022) The association
of antiviral drugs with COVID-19
morbidity: The retrospective analysis
of a nationwide COVID-19 cohort.
Front. Med. 9:894126.
doi: 10.3389/fmed.2022.894126
Frontiers in Medicine
Cenk Babayigit 1 , Nurdan Kokturk 2 , Seval Kul 3 ,
Pelin Duru Cetinkaya 4,5 , Sibel Atis Nayci 6 ,
Serap Argun Baris 7 , Oguz Karcioglu 8 , Pinar Aysert9 ,
Ilim Irmak10 , Aycan Akbas Yuksel11 , Yonca Sekibag12 ,
Oya Baydar Toprak 5 , Emel Azak 13 ,
Sait Mulamahmutoglu12 , Caglar Cuhadaroglu14 ,
Aslihan Demirel15 , Bugra Kerget16 , Burcu Baran Ketencioglu17 ,
Hasan Selcuk Ozger9 , Gulcihan Ozkan18,19 , Zeynep Ture 20 ,
Begum Ergan 21 , Vildan Avkan Oguz 22 , Oguz Kilinc 21 ,
Merve Ercelik 23 , Tansu Ulukavak Ciftci2 , Ozlem Alici24 ,
Esra Nurlu Temel 25 , Ozlem Ataoglu 23 , Asena Aydin26 ,
Dilek Cetiner Bahcetepe26 , Yusuf Taha Gullu 27 ,
Fusun Fakili 28 , Figen Deveci29 , Neslihan Kose 30 ,
Muge Meltem Tor 31 , Gulsah Gunluoglu32 , Sedat Altin 32 ,
Teyfik Turgut29 , Tibel Tuna27 , Onder Ozturk 33 ,
Oner Dikensoy 34 , Pinar Yildiz Gulhan 23 ,
Ilknur Basyigit 7 , Hasim Boyaci 7 ,
Ipek Kivilcim Oguzulgen2 , Sermin Borekci 12 ,
Bilun Gemicioglu 12 , Firat Bayraktar35 , Osman Elbek 36 ,
Ismail Hanta5 , Hacer Kuzu Okur14 , Gulseren Sagcan14 ,
Oguz Uzun27 , Metin Akgun 16 , Goksel Altinisik 37 ,
Berna Dursun38 , Ebru Cakir Edis 39 , Erkmen Gulhan 40 ,
Fusun Oner Eyuboglu 41 , Okkes Gultekin 42 ,
Yavuz Havlucu 42 , Metin Ozkan 38 ,
Aysin Sakar Coskun 42 , Abdullah Sayiner 43 ,
A. Fuat Kalyoncu10 , Oya Itil 21 and Hasan Bayram 44,45*
1
Department of Pulmonary Medicine, Faculty of Medicine, Mustafa Kemal University, Antakya,
Turkey, 2 Department of Pulmonary Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey,
3
Department of Biostatistics, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey,
4
Department of Pulmonary Medicine, Adana City Training and Research Hospital, University
of Health Sciences, Adana, Turkey, 5 Department of..
Late treatment
is less effective
babayigit
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit